Character Biosciences

Character Biosciences (Character Bio) is a precision medicine company focused on unlocking the genetic patterns underlying progressive polygenic diseases, with an initial emphasis on age-related macular degeneration (AMD). By leveraging proprietary genomic databases and advanced genetic analysis, Character Bio identifies patient subtypes and the genetic drivers of disease progression, aiming to enable the discovery and development of more effective, targeted therapies for complex eye diseases and potentially other conditions in the future. Their approach is geared toward advancing drug discovery and optimizing disease management for individuals based on their unique genetic and clinical profiles.